All products are for Professional Use Only (PUO) — not intended for human or animal consumption

Back to Learn
Cognitive & LongevityPeptide

Dihexa

A synthetic hexapeptide analog of angiotensin IV with potent nootropic properties. Preclinical studies have investigated cognitive signaling pathways through hepatocyte growth factor (HGF) pathway activation.

Mechanism of Action

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a modified angiotensin IV analog that acts as a potent agonist of the hepatocyte growth factor (HGF)/c-Met receptor system. Unlike angiotensin IV, which binds to the AT4 receptor (IRAP), dihexa primarily augments HGF signaling by stabilizing the HGF dimer and promoting its binding to the c-Met receptor on neurons. This activation stimulates synaptogenesis, dendritic spine formation, and neurotrophic signaling through PI3K and MAPK pathways. In animal studies, dihexa has demonstrated modulation of cognitive signaling pathways at picomolar concentrations, approximately seven orders of magnitude more potent than BDNF in promoting spinogenesis.

Research Applications

  • Studies have investigated cognitive signaling pathways in scopolamine-impaired rat models
  • Research has examined synaptogenesis and dendritic spine formation in vitro
  • Studies have explored HGF/c-Met pathway activation as a nootropic mechanism
  • Research has assessed potential applications in neurodegenerative disease research models

Key Published Studies

1

McCoy AT, et al. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. J Pharmacol Exp Ther. 2013;344(1):141-154.

Key finding: Research investigated dihexa-mediated HGF/c-Met receptor activation and its effects on cognitive signaling pathways in rat models, observing modulation of synaptic connectivity at concentrations approximately 10 million-fold lower than BDNF.

2

Sun X, et al. AngIV-analog dihexa rescues cognitive impairment and recovers memory in the APP/PS1 mouse via the PI3K/AKT signaling pathway. Brain Sci. 2021;11(11).

Key finding: Dihexa improved performance on memory tasks in the APP/PS1 mouse, with the authors attributing the effect to PI3K/AKT signalling.

Research Use Only (RUO): This page summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. The compound described carries a Research Use Only designation and is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in the diagnosis, treatment, cure, or prevention of any disease. Consult qualified professionals before making any health-related decisions.

i2b Health Research Supply
RESEARCH USE ONLY

Age Verification Required

You must be 21 years of age or older to access this website. All products are intended for qualified researchers and laboratory use only.

By entering this site, you confirm that you are at least 21 years of age, that anything you acquire here is for research purposes, and that you agree to our Terms of Service and Research Use Only policy. Products are not intended for human or animal consumption.